Abstract

Centronuclear myopathy (CNM) is a group of rare genetic muscle disorders characterized by muscle fibers with centrally located nuclei. The most common forms of CNM have been attributed to X-linked recessive mutations in the MTM1 gene; autosomal-dominant mutations in the DNM2 gene-encoding dynamin-2, the BIN1 gene; and autosomal-recessive mutations in BIN1, RYR1, and TTN genes. Dominant CNM due to DNM2 mutations usually follows a mild clinical course with the onset in adolescence. Currently, around 35 mutations of the DNM2 gene have been identified in CNM; however, the underlying molecular mechanism of DNM2 mutation in the pathology of CNM remains elusive, and the standard clinical characteristics have not yet been defined. Here, we describe the case of a 17-year-old female who presented with proximal muscle weakness along with congenital anomalous pulmonary venous connection (which has not been described in previous cases of CNM), scoliosis, and lung disease without a significant family history. Her creatine kinase level was normal. Histology, special stains, and electron microscope findings on her skeletal muscle biopsy showed CNM with the characteristic features of a DNM2 mutation, which was later confirmed by next-generation sequencing. This case expands the known clinical and pathological findings of CNM with DNM2 gene mutation.

Highlights

  • Centronuclear myopathy (CNM) is a rare congenital myopathy, which was first described as myotubular myopathy by Spiro et al.[1] in 1966

  • CNM is a rare congenital myopathy, which can be diagnosed based on histology

  • Three forms of the disease are clinically recognized: (i) the X-linked severe neonatal form, which is caused by MTM1 mutation; (ii) the autosomal recessive childhood onset form, which is usually caused by bridging integrator 1 gene (BIN1) mutation; and (iii) the autosomal dominant adult-onset form, which is caused by dynamin 2 (DNM2) mutation

Read more

Summary

INTRODUCTION

Centronuclear myopathy (CNM) is a rare congenital myopathy, which was first described as myotubular myopathy by Spiro et al.[1] in 1966. Abnormal genital development occurs.[9] Heterozygous female carriers may present with limb girdle and facial weakness.[10] Mutations in MTM1 have been recognized as the underlying cause of atypical forms of XLMTM in newborn boys, female infants, and adult men and women, which presents a histological alteration in some muscle fibers that resemble a necklace (“necklace fibers”).[11] Muscle biopsies from XLMTM patients show numerous fibers with central nuclei resembling myotubes, which are frequently surrounded by a paler peripheral halo. It is caused by a mutation in dynamin 2 (DNM2) on chromosome 19.20 The most prominent histopathological features include the frequency of centrally located nuclei

Heterozygous female carriers may present with limb girdle and facial weakness
CASE REPORT
Findings
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call